Morgan Stanley is emerging as a leading contender for a key role in SpaceX's blockbuster initial public offering, as the bank's close ties to CEO Elon Musk give it an edge in his decision, according t... ...

galaxy digital's tokenized glxy equity trading 30% below traditional shares after december 15 dump. same sec-registered stock, same $505m quarterly profit, same voting rights. jpmorgan just issued $50m commercial paper for galaxy on solana december 11. morgan stanley has $42 target on traditional shares currently at $28. tokenized equity arbitrage is live. ...

Core Viewpoint - Aether Holdings, Inc. has appointed Wayne Huo as an independent member of its Board of Directors, aiming to enhance its product strategy and governance in the integration of data and AI across its offerings [1][2]. Group 1: Appointment and Experience - Wayne Huo brings extensive experience in digital assets, capital markets, and public companies to Aether's Board [2]. - Huo co-founded Amber Group, a global digital-asset company, and served as CEO of its Nasdaq-listed subsidiary until August 2025 [3]. - He has a background as an FX options trader at Morgan Stanley and holds advanced degrees in Mathematical Finance and Applied Mathematics, Finance, and Economics [3]. Group 2: Strategic Vision - Huo expressed enthusiasm about joining Aether at a time when data, AI, and investor education are converging, emphasizing the need for an integrated investor ecosystem [4]. - Aether's CEO, Nicolas Lin, highlighted that Huo's experience in institutional trading and governance aligns with the company's mission to scale its platform and enhance its investor ecosystem [4]. Group 3: Company Overview - Aether Holdings, Inc. is focused on advancing how investors access and analyze market information through data-driven platforms [5]. - The company provides market intelligence platforms and financial newsletters that convert complex data into actionable insights for investors [6]. - Aether is committed to innovation, transparency, and thought leadership in enhancing the investing experience across the global financial ecosystem [7].

Market Overview - The article discusses the potential for strong market momentum to continue into 2026, with a focus on identifying the next wave of multibagger stocks [1][2] - Chris Toomey from Morgan Stanley expects a solid year for markets in 2026, driven by secular tailwinds, improving earnings visibility, supportive fiscal and monetary policies, and a revival of market enthusiasm due to deregulation and increased M&A activity [3][4] Investment Strategy - Toomey emphasizes the importance of market leadership broadening, suggesting that previously overlooked sectors may present new investment opportunities, moving beyond the dominance of mega-cap technology stocks [5] - The methodology for selecting the best multibagger stocks includes filtering for stocks with a market capitalization over $500 million, at least 150% returns over the past year, and a minimum of 50% upside potential [7] Company Highlights CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Market Cap: $696.38 million, with a 1-year price return of 263.72% and an upside potential of 58.20% [9] - 90% of analysts are bullish on CTMX, with a median price target of $6.50, indicating a healthy upside potential [10] - H.C. Wainwright has reiterated a "Buy" rating with a $10.00 price target, anticipating critical data for the CX-2051 therapy in colorectal cancer [11] - The firm outlines performance benchmarks for CX-2051, categorizing potential outcomes into "slam dunk," "bull," and "bear" scenarios based on expected response rates and survival metrics [12] - The company is progressing with its CX-2051 program, with enrollment nearing 100 patients ahead of a planned Phase 1 update in Q1 2026 [13][14] Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Market Cap: $1.59 billion, with a 1-year price return of 169.11% and an upside potential of 73.40% [15] - The appointment of David Hastings as CFO is seen as a strategic move to support the company's transition into advanced development stages [16] - Trevi is preparing for a Phase 3 program for Haduvio in chronic cough associated with idiopathic pulmonary fibrosis (IPF), with an End-of-Phase 2 meeting with the FDA expected in Q4 2025 [17] - Ongoing studies have shown no safety signals, and the company has a cash balance of $194.9 million as of Q3 2025, positioning it well for future clinical developments [18][19]

While much of the market has bulked up on artificial intelligence and large technology companies in 2025, billionaire fund manager Ron Baron said on this week's CNBC "ETF Edge" that investors should be looking across more market caps and sectors for the best opportunities. That is starting to happen, as many investors rotate out of tech stocks and search for value across the market, including in the financial sector. Baron cited two financial sector companies that his firm Baron Capital owns, MSCI and FactS ...

Brazilian sanitation company Aegea is working with BTG Pactual, Itau and Morgan Stanley for a potential IPO in 2026, according to people familiar with the matter https://t.co/ueOswOpVXP ...

RT Bitcoin Magazine (@BitcoinMagazine)JUST IN: Michael Saylor pictured at Morgan Stanley 👀 https://t.co/tKH3XeI4nv ...

JUST IN: Michael Saylor pictured at Morgan Stanley 👀 https://t.co/tKH3XeI4nv ...

Core Viewpoint - Morgan Stanley maintains an "Overweight" rating for Rio Tinto, indicating confidence in the stock's potential and a positive outlook for the company's future performance [1][5]. Company Overview - Rio Tinto is a leading global mining group focused on finding, mining, and processing mineral resources, operating in segments such as iron ore, aluminum, copper, and diamonds [1]. - The company competes with other mining giants like BHP and Vale, highlighting its significant presence in the industry [1]. Stock Performance - At the time of the announcement, RIO's stock price was $76.02, with a slight increase to $75.99, reflecting a change of 0.17 or 0.22% [2]. - The stock has traded between $75.85 and $76.73 on the day, with a yearly high of $76.99 and a low of $51.67, indicating volatility and potential for growth [3][5]. - RIO's market capitalization is approximately $123.38 billion, underscoring its substantial presence in the mining sector [3]. Trading Activity - The trading volume for RIO is 1,930,571 shares, indicating active investor interest and reflecting the market's perception of the company's value [4].

Core Insights - Bank of America Corporation (NYSE:BAC) is recognized as one of the 15 Best Blue-Chip Stocks with Growing Dividends [1] - Morgan Stanley has reduced its price target for Bank of America to $68 from $70, while maintaining an Overweight rating, reflecting adjustments in earnings expectations due to softer investment banking fees and higher expenses [2] - Bank of America’s shares reached a record high of $55.14, the first since before the 2008 financial crisis, symbolizing a significant recovery for the bank [3] Financial Performance and Strategy - Following the 2008 financial crisis, Bank of America undertook a long recovery process, closing hundreds of underperforming branches and reducing its workforce significantly, while expanding Merrill Lynch's operations and growing its consumer and commercial banking footprint [4] - The bank's deposits have reached $1.96 trillion, making it the second-largest in the U.S. after JPMorgan Chase [4] - At its recent investor day, CEO Brian Moynihan set financial targets aiming for returns on tangible common equity of 16% to 18% over the next three to five years, emphasizing the importance of coordination across business lines [5] Company Overview - Bank of America Corporation is a global financial institution with a comprehensive platform that includes banking, investing, wealth management, and lending services for both individual and institutional clients worldwide [6]